Geographic · Net Sales

Other European countries — Net Sales

West Pharmaceutical Services Other European countries — Net Sales remained flat by 0.0% to $112.75M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 17.0%, from $96.38M to $112.75M. Over 4 years (FY 2021 to FY 2025), Other European countries — Net Sales shows an upward trend with a 7.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ1 2016
Last reportedQ4 2025
Rolls up toTotal Revenue

How to read this metric

An increase indicates successful market expansion or higher demand for pharmaceutical components in these specific regions, while a decrease may signal competitive pressure or economic headwinds in those territories.

Detailed definition

This metric represents the total revenue generated from customers located in European countries outside of the company's...

Peer comparison

Peers in the medical device and pharmaceutical supply chain typically report regional revenue splits to highlight geographic concentration risk and growth opportunities.

Metric ID: wst_segment_other_european_countries_net_sales

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value$341.30M$359.20M$388.10M$385.50M$451.00M
YoY Change+5.2%+8.0%-0.7%+17.0%
Range$341.30M$451.00M
CAGR+7.2%
Avg YoY Growth+7.4%
Median YoY Growth+6.6%

Frequently Asked Questions

What is West Pharmaceutical Services's other european countries — net sales?
West Pharmaceutical Services (WST) reported other european countries — net sales of $112.75M in Q4 2025.
How has West Pharmaceutical Services's other european countries — net sales changed year-over-year?
West Pharmaceutical Services's other european countries — net sales increased by 17.0% year-over-year, from $96.38M to $112.75M.
What is the long-term trend for West Pharmaceutical Services's other european countries — net sales?
Over 4 years (2021 to 2025), West Pharmaceutical Services's other european countries — net sales has grown at a 7.2% compound annual growth rate (CAGR), from $341.30M to $451.00M.
What does other european countries — net sales mean?
Total revenue earned from sales to customers in secondary European markets.